Early environmental origins of neurodegenerative disease in later life

Environmental Health Perspectives

Volumn 113, Issue 9, 2005, Pages 1230-1233

  Landrigan, Philip J ^a   Sonawane, Babasaheb ^b   Butler, Robert N ^c   Trasande, Leonardo ^a   Callan, Richard ^a   Droller, Daniel ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c International Longevity Center   (United States)

Author keywords

Alzheimer disease; Maneb; Manganese; National Children's Study; Neurodegenerative disease; Paraquat; Parkinson disease; Pesticides

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; LEAD; MANEB; MANGANESE; METHYLCYCLOPENTADIENYLMANGANESE TRICARBONYL; METHYLMERCURY; ORGANOCHLORINE PESTICIDE; PARAQUAT; PESTICIDE; POLYCHLORINATED BIPHENYL; ROTENONE;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DEMENTIA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE COST; HEREDITY; HIGH RISK POPULATION; HUMAN; HYPOTHESIS; INCIDENCE; INTELLIGENCE; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; WORKER;

AGE FACTORS; ALZHEIMER DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; PARKINSON DISEASE; REGISTRIES;

EID: 25844476202     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7571     Document Type: Review

References (59)

1. Alzheimer's Association. 2003. About Alzheimer's Disease. Available: http://www.alz.org/AboutAD/Causes.htm [accessed 12 July 2003].
2. Baldi I, Lebailly P, Mohammed-Brahim B, Letenneur L, Dartigues JF, Brochard P. 2003. Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol 157:409-414.
3. Barker D, Osmond C, Simmonds S, Wield G. 1993. The relation of small head circumference and thinness at birth to death from cardiovascular disease in later life. BMJ 306:422-426.
4. Ben-Shlomo Y. 1997. The epidemiology of Parkinson's disease. Baillieres Clin Neurol 6:55-68.
5. Berkowitz GS, Wolff MS, Matte T, Susser E, Landrigan PJ. 2001. The rationale for a national prospective cohort study of environmental exposure and childhood development. Environ Res 85:59-68. Available: http://nationalchildrensstudy.gov [accessed 14 July 2003].
6. Brookmeyer R, Gray S, Kawas C. 1998. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Pub Health 88:1337-1342.
7. Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ. 1999. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 823:1-10.
8. Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. 2003. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348:1517-1526.
9. CDC. 2003a. Deaths: Preliminary Data for 2001. National Vital Statistics Reports, Vol 51, No 5. Rockville, MD:Centers for Disease Control and Prevention, National Center for Health Statistics.
10. CDC. 2003b. Second National Report on Exposure to Environmental Chemicals. Atlanta, GA:Centers for Disease Control and Prevention.
11. Dawson TM, Dawson VL. 2003. Molecular pathways of neurogeneration in Parkinson's Disease. Science 302:819-922.
12. De la Fuente-Fernandez R, Calne D. 2002. Evidence for environmental causation of Parkinson's disease. Parkinsonism Relat Disord 8:235-241.
13. Fleming L, Mann JB, Bean J, Briggle T, Sanchez-Ramos JR. 1994. Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol 36:100-103.
14. Foster H. 2002. Why the preeminent risk factor in sporadic Alzheimer's disease cannot be genetic. Med Hypoth 59:57-61.
15. Gao HM, Hong JS, Zhang W, Liu B. 2003. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci 23:1228-1236.
16. Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B. 2002. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 81:1285-1297.
17. Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K, et al. 1997. Cognitive deficit in 7-year old children with pre-natal exposure to methylmercury. Neurotoxicol Teratol 19:417-428.
18. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. 2002. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52:276-284.
19. Hinchliffe S, Lynch M, Sargent P, Howard C, Van Velzen D. 1992. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 99:296-301.
20. Jacobson JL, Jacobson SW, Humphrey HE. 1990. Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J Pediatr 111:38-45.
21. John C. Robbins Associates. 1997. Study prepared for the Parkinson's Disease Foundation, New York City, cited in press release dated 20 April 1998. New York:John C. Robbins Associates.
22. Kennedy JL, Farrer LA, Andreason NC, Mayeux R, St. George-Hyslop P. 2003. The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 302:822-826.
23. L-Dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice. Infect Immunol 59:181-191.
24. Kurland LT, Mulder DW. 1954. Epidemiologic investigations of amyotrophic lateral sclerosis. 1: Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathological observations. Neurology 4:355-378, 438-448.
25. Landrigan PJ, Kimmel CA, Correa A, Eskenazi B. 2003. Children's health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect 112:257-265.
26. Langston W, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D. 1999. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. J Ann Neurol 46:598-605.
27. Law C, De Swiet M, Osmond C, Fayers P, Barker D, Cruddas A, et al. 1993. Initiation of hypertension in utero and its amplification throughout life. BMJ 306:24-27.
28. Lewin Group. 2001. Medicare and Medicaid Costs for People with Alzheimer's Disease. Alzheimer's Association. Available: http://www.alz.org/Media/newsreleases/alzreport.pdf [accessed 7 January 2004].
29. Lilienfeld DE, Sekkor D, Simpson S, Perl DP, Ehland J, Marsh G, et al. 1990. Parkinsonism death rates by race, sex and geography: a 1980s update. Neuroepidemiology 9:243-247.
30. Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, et al. 1997. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48:1583-1588.
31. Liu B, Du L, Hong JS. 2000. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 293:607-617.
32. Liu B, Gao H, Hong J. 2003. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect 111:1065-1073.
33. Liu B, Hong JS. 2003. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1-7
34. Lumbers ER, Yu ZY, Gibson KJ. 2001. The selfish brain and the Barker hypothesis. Clin Exp Pharmacol Physiol 28(11):942-947.
35. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, et al. 2002. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119-127.
36. Mergler D, Baldwin M. 1997. Early manifestations of manganese neurotoxicity in humans: an update. Environ Res 73:92-100.
37. National Institute of Neurological Disorders and Stroke. 2004. Parkinson's Disease Backgrounder. Bethesda, MD:National Institute of Neurological Disorders and Stroke. Available: http://www.ninds.nih.gov/health_and_medical/pubs/ parkinson's_disease_backgrounder.htm [accessed 6 January 2004].
38. Needleman HL, Landrigan PJ. 1996. Toxins at the pump. New York Times, Op-Ed. 13 March: 15.
39. Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. 1990. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med 322:83-88.
40. NIA. 2000. Progress Report on Alzheimer's Disease. Bethesda, MD:National Institute on Aging. Available: http://www.alzheimers.org/pubs/prog00.htm [accessed 6 January 2004].
41. Orr CF, Rowe DB, Halliday GM. 2002. An inflammatory review of Parkinson's disease. Prog Neurobiol 68:325-340.
42. Osmond C, Barker D. 2000. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 108(suppl 3):545-553.
43. Osmond C, Barker D, Winter P, Fall C, Simmonds S. 1993. Early growth and death from cardiovascular disease in women. BMJ 307:1519-1524.
44. Parkinson's Disease Foundation. 2004. Symptoms. Available: http://www.pdf.org/AboutPD/symptoms.cfm [accessed 6 January 2004].
45. Plato C, Garruto R, Galasko D, Craig U, Plato M, Gamst A, et al. 2003. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 157:149-157.
46. Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. 2001. Environmental risk factors and Parkinson's disease: a meta-analysis. Environ Res 86:122-127.
47. Schwartz BS, Stewart WF, Bolla KI, Simon PD, Bandeen-Roche K, Gordon PB, et al. 2000. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 55:1144-1150.
48. Seawright A, Ng J, Kurland L, Osborne R, de Matteis F. 1995. The occurrence and possible health significance of toxins in cycad pollen. In: Proceedings of the Third International Conference on Cycad Biology (Vorster P, ed). Pretoria, South Africa:University of Pretoria, 97-107.
49. Sherer TB, Kim J-H, Betarbet R, Greenamyre JT. 2003. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp Neurol 179:9-16.
50. Siderowf A, Stern M. 2003. Update on Parkinson Disease. Ann Intern Med 138:651-658.
51. Slotkin TA. 2004. Guidelines for developmental neurotoxicity and their impact on organophosphate pesticides: a personal view from an academic perspective. Neurotoxicology 25:631-640.
52. Spencer PS. 2003. Food toxins, AMPA receptors, and motor neuron diseases. Drug Metab Rev 31:561-587.
53. Stewart WF, Schwartz BS, Simon D, Bolla KI, Todd AC, Links J. 1999. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology 52:1610-1617.
54. Stewart WF, Schwartz BS, Simon D, Kelsey K, Todd AC. 2002. ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ Health Perspect 110:501-505.
55. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, et al. 1999. Parkinson disease in twins: an etiologic study. JAMA 281:341-346.
56. Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA. 2000a. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res 873:225-234.
57. Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA. 2000b. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J Neurosci 20:9207-9214.
58. Twelves D, Perkins K, Counsell C. 2003. Systematic review of incidence studies of Parkinson's disease. Mov Disord 18:19-31.
59. Wilson R, Schneider J, Bienias J, Evans D, Bennett D. 2003. Parkinsonian like signs and risk of incident Alzheimer disease in older persons. Arch Neurol 60:539-544.